Loading...
Last update:  May 26, 2023
08:28 +1GMT

Allergenic Molecule  Phl p 2Homo sapiens  
Epidemiology from Literature
CohortYearCountryTestSubjectsPositive (%)Bibliography
1.1 - Asymptomatic2014SpainIgE500.00020140625, Armentia A
1.10 - Any allergy symptom, Diagnosed2010BelgiumIgE8615.11020101214, Gadisseur R
1.10 - Any allergy symptom, Diagnosed2014BrazilIgE3455.90020141118, Santiago HD
1.10 - Any allergy symptom, Diagnosed2014BrazilIgE3033.30020141118, Santiago HD
1.10 - Any allergy symptom, Diagnosed2010ItalyIgE1640820.72020100301, Scala E
1.11 - Esophagitis, Diagnosed2013NetherlandsIgE7621.10020131020, van Rhijn BD
1.11 - Esophagitis, Diagnosed2014SpainIgE674.50020140625, Armentia A
1.11 - Esophagitis, Diagnosed2013SwitzerlandIgE3551.43020130605, Simon D
1.2.1 - Asthma, Diagnosed (Adults)2012SwedenIgE9618.75020120528, Patelis A
1.5 - Atopic Dermatitis, Diagnosed2013GermanyIgE14017.14020130111, Ott H
1.5 - Atopic Dermatitis, Diagnosed2009GermanyIgE2025.00020091005, Ott H
1.9 - Pollen Allergy2014Czech RepublicIgE82628.70020140606, Panzner P
1.9 - Pollen Allergy2014SpainIgE5032.00020140625, Armentia A
10.1 - Normal Control2012BelgiumIgE270.00020110223, De Knop KJ
10.1 - Normal Control2009BelgiumIgE260.00020091121, Ebo DG
3.1.1 - Source Sensitized (SPT)2003ItalyIgE74954.900
3.1.4 - Source Sensitized (SPT, IgE)2001ItalyIgE7767.500
3.2.1 - Source Sensitized (IgE)2003AustriaIgE2568.000
3.2.1 - Source Sensitized (IgE)2005FinlandIgE5728.000
3.2.1 - Source Sensitized (IgE)2002Not DefinedIgE18456.000
3.2.1 - Source Sensitized (IgE)2000Not DefinedIgE30659.800
3.2.1 - Source Sensitized (IgE)2005Russian FederationIgE120.000
3.2.1 - Source Sensitized (IgE)2003ZimbabweIgE250.000
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2012AustriaIgE5429.60020120310, Twaroch TE
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2009BelgiumIgE2213.64020091121, Ebo DG
4.1.4 - Heterologous Source Sensitized (Symptoms, IgE)2012ItalyIgE2650.00020120310, Twaroch TE
4.1.5 - Heterologous Source Sensitized (IgE)2009BelgiumIgE2070.00020091121, Ebo DG
4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE)2009BelgiumIgE3748.64020090826, Ebo DG
5.2.1 - Source Exposed (Symptoms, SPT)1996AustriaIgE2969.000
5.2.1 - Source Exposed (Symptoms, SPT)1996CanadaIgE1520.000
5.2.1 - Source Exposed (Symptoms, SPT)1996DenmarkIgE2677.000
5.2.1 - Source Exposed (Symptoms, SPT)1996FranceIgE3858.000
5.2.1 - Source Exposed (Symptoms, SPT)1996JapanIgE2010.000
5.2.1 - Source Exposed (Symptoms, SPT)2014SpainIgE10356.20020141003, Beitia JM
5.2.1 - Source Exposed (Symptoms, SPT)2011SpainIgE4362.80020110713, Cabrera-Freitag P
5.2.1 - Source Exposed (Symptoms, SPT)1996SwedenIgE3534.000
5.2.1 - Source Exposed (Symptoms, SPT)1996SwitzerlandIgE2030.000
5.3.1 - Source Exposed (Symptoms, IgE)1994AustriaIgE3060.000
5.3.1 - Source Exposed (Symptoms, IgE)2012BelgiumIgE9934.34020110223, De Knop KJ
5.3.1 - Source Exposed (Symptoms, IgE)2014GermanyIgE10157.42020140306, Darsow U
5.3.1 - Source Exposed (Symptoms, IgE)2014SwedenIgE3711.00020140127, Konradsen JR
5.3.1 - Source Exposed (Symptoms, IgE)2014SwedenIgE2818.00020140127, Konradsen JR
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2013AustriaIgE4953.00020131014, Bokanovic D
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2013AustriaIgE4953.00020131014, Bokanovic D
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2013AustriaIgE4949.00020131014, Bokanovic D
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2008AustriaIgE8282.90020080314, Westritschnig K
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2000ItalyIgE27686.900
6.2 - General Population (Adults)2012SwedenIgE3713.77020120528, Patelis A
5.3.1 - Source Exposed (Symptoms, IgE)2006GermanyIgE (IB)7057.10020060602, Petersen A
5.4.1 - Source Exposed (Symptoms, SPT, IgE)1993AustriaIgE (IB)9862.000
5.4.1 - Source Exposed (Symptoms, SPT, IgE)2008AustriaSPT8259.75020080314, Westritschnig K
Developed by
Panservice